You need to extend your research before you post misleading information.
You are saying small/thin veins are concerning for offtake opportunities. Do you call 20m to 60m veins thin/small?
l personally don't call these veins thin or small. These veins are simular to TAW, except LTR's are 35% higher grade at KV.
Buldania our second discovery is going to be just as good as KV.
Mineralisation at both sites are spodumene related.
Could you please explain why TAW had no problems in getting an offtake agreement with what you call thin/small veins.
Just look at the market caps
LTR is $28 million with a scoping study out shortly.
They are also looking at being in production btw late 2020 and early 2021.
Theres more value to be added with their Vanadium resource.
TAW and their merger have a combined market cap of approx. $350 million
This a no brainer.
Below is a section of TAW pegmatite which you consider is to thin/small.
LTR's sections look better than this.
Now l will let the results of the scoping study speak for themselves.
- Forums
- ASX - By Stock
- LTR
- Big day by the looks
Big day by the looks, page-26
-
- There are more pages in this discussion • 27 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add LTR (ASX) to my watchlist
(20min delay)
|
|||||
Last
84.5¢ |
Change
-0.010(1.17%) |
Mkt cap ! $1.612B |
Open | High | Low | Value | Volume |
85.0¢ | 86.5¢ | 83.5¢ | $5.151M | 6.083M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 23487 | 84.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
85.0¢ | 286512 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
10 | 1641167 | 0.019 |
3 | 712500 | 0.018 |
3 | 794117 | 0.017 |
1 | 200000 | 0.015 |
1 | 60000 | 0.014 |
Price($) | Vol. | No. |
---|---|---|
0.020 | 1985261 | 1 |
0.021 | 1256198 | 4 |
0.022 | 1128862 | 5 |
0.023 | 1750000 | 3 |
0.024 | 480229 | 3 |
Last trade - 16.10pm 18/11/2024 (20 minute delay) ? |
Featured News
LTR (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
SPONSORED BY The Market Online